Aardvark released exploratory data from its stopped Phase 3 HERO trial in Prader-Willi syndrome after FDA lifted the hold, and plans a redesigned Phase 3.
|Articles|April 14, 2023
People and Business News – 4/23
The latest people and business news from the past month, all in one place.
Advertisement
People News
MMS Holdings announced the addition of Dr. Philip Breitfeld and Dr. Bernhardt Zeiher to its board of scientific advisors. Dr. Breitfeld is currently the chief medical officer for Allterum Therapeutics. Dr. Zeiher has also been the chief medical officer for Astellas Pharma for the past 12 years.
Catawba Research announced the hiring of Andy Silverman, PhD, as chief operating officer. Previously, Silverman worked as EVP, Global Operations for Syneos Health.
Greenphire announced the appointment of Steve Geffon to be its new chief commercial officer. Prior to joining Greenphire, Geffon spent three years in the same role at Science 37.
CluePoints revealed the hiring of Amit Patel as its new CFO. Patel joins CluePoints after serving in the same role at Siteimprove.
Innovative Trials appointed Eloise Moffett as its first commercial vice president. Before joining Innovative Trials, Moffet spent over two years as the senior director of business development for mdgroup.
EmVenio Research announced the appointment of Mark Mackenzie, MD, as chief medical officer. Previously, Mackenzie served as the vice president of clinical affairs at M-3 Wake Research.
COTA Inc. announced the hiring of Sandy Leonard as its chief commercial officer. Concurrently, Leonard is the founder of DAISE Consulting LLC.
TOTAL Diversity Clinical Management introduced three new executives to its staff including Gabrielle DeBoer as VP, business development; Jeremy Mitchell as director, business development; and Crystal Thigpen as marketing and communications director.
Recognition
Cluepoints has been shortlisted for the 2023 Citeline Awards in the Best Use of Artificial Intelligence in Clinical Trials category.
Advertisement
Related to this article
Clinical trials capture data faster than ever, but the real bottleneck is the distance between data capture and a decision teams can trust.
In today’s ACT Brief, we examine why the future of AI in trials is a trusted orchestration system rather than a single model, how coordinators rate eSource-enabled workflows, and what a bipartisan bill proposes for reusable trial networks.
The Faster Clinical Trials Act would create an FDA Center for Clinical Trial Innovation and aims to cut trial costs and enrollment time by at least 30%.
Standardized measurement across five oncology centers found that clinical research coordinators rated eSource-enabled workflows positively (Overall Mean Satisfaction 5.79 of 7), with reduced manual entry and electronic data transfer earning strong marks, while perceived reduction in sponsor and monitor queries lagged as the one domain below threshold.
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.
In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
Pacing obesity trial enrollment, anchoring eligibility to stable real-world therapies, and building site and physician relationships improve retention and data quality more than aggressive recruitment or restrictive exclusion criteria do.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clinical Trials Do Not Have a Data Problem, They Have a Decision-Readiness Problem
2
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
3
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
4
ACT Brief: Orchestrated AI Clinical Environments, eSource Coordinator Satisfaction, and Faster Clinical Trials Act
5